Arkolith/Insider Trading/HALO/Form 4

Torley Helen

PRESIDENT AND CEO, DirectorHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed May 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.4M
Net Open-Market Flow
-$3.4M
Transactions
18
15 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Sell(S)2K$68.10$143K776K
May 13, 2026Sell(S)3K$68.88$231K772K
May 13, 2026Sell(S)4K$69.79$276K768K
May 13, 2026Sell(S)600$70.81$42K768K
May 13, 2026Option exercise(M)10K$12.07$121K778K
May 12, 2026Sell(S)100$67.85$7K788K
May 12, 2026Sell(S)1K$70.29$98K786K
May 12, 2026Sell(S)10K$71.37$700K776K
May 12, 2026Sell(S)6K$72.15$426K771K
May 12, 2026Sell(S)3K$73.12$205K768K
May 12, 2026Option exercise(M)20K$12.07$241K788K
May 11, 2026Option exercise(M)20K$12.07$241K788K
May 11, 2026Sell(S)10K$64.63$629K778K
May 11, 2026Sell(S)4K$65.46$234K774K
May 11, 2026Sell(S)7K$66.33$444K768K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2026Option exercise(M)10K$12.07$121K52K
May 12, 2026Option exercise(M)20K$12.07$241K62K
May 11, 2026Option exercise(M)20K$12.07$241K82K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML